Skip to content

Clinical trials

Phase 1/2 Dermatomyositis trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Dermatomyositis Phase: Phase 1/2 Clear all

7 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20191
20211
20231
20241
20251
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting4
Completed1
Enrolling by invitation1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Cartesian Therapeutics1
Fate Therapeutics1
Fondazione Policlinico Universitario Agostino Gemelli IRCCS1
Indiana University1
Miltenyi Biomedicine GmbH1
National Institute of Blood and Marrow Transplant (NIBMT), Pakistan1
Paean Biotechnology Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Dermatomyositis7
Lupus Erythematosus, Systemic4
Polymyositis4
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis3
Scleroderma, Systemic3
Arthritis, Juvenile2
Arthritis, Rheumatoid2
Arthritis1
Autoimmune Diseases1
Myositis1

Trials

Showing 76 to 7 of 7. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.